USANA Health Sciences, Inc. filings document financial results, management commentary and Regulation FD disclosures for a health and wellness products company. Form 8-K reports cover quarterly and annual results, preliminary sales information, guidance, exhibits and conference-call materials tied to the company’s operating updates.
Proxy and governance filings address director elections, board matters, executive compensation, equity awards and pay-versus-performance disclosure. Other material-event reports document leadership changes, transition agreements and compensatory arrangements, providing formal records of governance and management structure for USANA Health Sciences.
USANA Health Sciences (USNA) – Form 4 filed 07/28/2025. Director Timothy E. Wood reported transactions dated 07/24/2025 involving restricted stock units (RSUs) and common shares.
- RSU exercise (Code M): 1,058 RSUs converted into an equal number of common shares at a stated price of $0.
- Disposition for tax withholding (Code F): 265 shares sold at $32.09 per share.
After the transactions Wood now directly owns 8,235 common shares. He also retains 3,172 unvested RSUs that convert 25 % on 07/24/2025, 10/23/2025, 01/22/2026, and 04/23/2026.
The filing reflects a net increase of 793 shares in Wood’s direct equity position and provides updated ownership data but does not contain company-level financial results or forward-looking statements.